The majority of animal studies on methylphenidate (MP) use intraperitoneal (IP) injections,
subcutaneous (SC) injections, or the oral gavage route of administration. While all these …

Aims Animal studies suggest that methylphenidate treatment for around 3 months may lead
to less mineralized and weaker appendicular bones. A systematic review was conducted to …

Aim Attention‐deficit‐hyperactivity disorder (ADHD) is a disorder that is associated with
accidental injuries. The aim of this study was to evaluate the relationship between ADHD …

Methylphenidate (MP) is frequently prescribed to treat Attention-Deficit/Hyperactivity
Disorder (ADHD); however, many patients with ADHD experience depression and anxiety …

Most animal studies using methylphenidate (MP) do not administer it the same way it is
administered clinically (orally), but rather by injection, resulting in an altered …

Methylphenidate (MP) is a widely prescribed psychostimulant used to treat attention deficit
hyperactivity disorder. Previously, we established a drinking paradigm to deliver MP to rats …

We performed a meta-analysis to quantify the relationships among a diagnosis of attention-
deficit/hyperactivity disorder (ADHD), the use of stimulant medication, and the risk of fracture …

Methylphenidate (MP) is the most prescribed psychostimulant for ADHD patients, with
clinically demonstrated detrimental effects on bone quality, potentially leading to early onset …

Chronic oral methylphenidate (MP) exposure in rats is associated with numerous
developmental and behavioral consequences. The present study investigated the …

Methylphenidate (MP), a widely used and abused stimulant medication for ADHD,
negatively affects bone mass. However, previous epidemiological studies demonstrated that …